MEI Pharma Stock Quote MEIP - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

2.84

Bid

2.80

Ask

3.03

Volume

15,650

2.78 Day's Range 2.93

2.7293 52 Week Range 7.8734

Market Cap

19.322M

Previous Close

2.90

Open

2.93

Last Trade

2.94

Last Trade Time

Financial Volume

$ 44,713

VWAP

2.857

Average Volume (3m)

16,928

Shares Outstanding

6,662,857

Dividend Yield

PE Ratio

-0.59

Earnings Per Share (EPS)

-4.78

Revenue

48.82M

Net Profit

-31.84M

MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical deve... MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.meipharma.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

MEI Pharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MEIP. The last closing price for MEI Pharma was $2.90. Over the last year, MEI Pharma shares have traded in a share price range of $ 2.7293 to $ 7.8734.

MEI Pharma currently has 6,662,857 shares outstanding. The market capitalization of MEI Pharma is $19.32 million. MEI Pharma has a price to earnings ratio (PE ratio) of -0.59.

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights

-- Ongoing Phase 1 Study Evaluating Voruciclib Plus Venetoclax Demonstrates Anti-leukemic Activity, Including Complete Responses, Anticipated Decreases in Mcl-1 and No Overlapping Toxicity in...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344

– MEI Pharma Board Unanimously Determines, Based on Clinical Data Results, Not to Proceed with Second Capital Return Under 2023 Anson and Cable Car Cooperation Agreement: Conserving Capital...

MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients

– Cohort 1 Exceeds Predetermined Non-Progression Threshold in the Ongoing Phase 1b Study – – ME-344 in Combination with Bevacizumab was Generally Well-tolerated with no Evidence of Overlapping...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.04	1.42857142857	2.8	2.93	2.78	9039	2.83881828	CS
4	-0.02	-0.699300699301	2.86	2.95	2.78	12337	2.8385181	CS
12	-0.38	-11.801242236	3.22	3.45	2.7293	16928	2.94259777	CS
26	-2.94	-50.8650519031	5.78	5.88	2.7293	20450	3.7085825	CS
52	-4.66	-62.1333333333	7.5	7.8734	2.7293	33738	5.76442368	CS
156	-51.36	-94.7601476015	54.2	71	2.7293	1228530	18.04170951	CS
260	-38.76	-93.1730769231	41.6	91.5	2.7293	1103882	31.61713554	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AMIXAutonomix Medical Inc	$ 1.3701 (121.70%)	154.81M
SHOTWSafety Shot Inc	$ 0.41 (115.79%)	7.56k
DATSDatChat Inc	$ 1.89 (81.73%)	54.75M
CYNCYNGN Inc	$ 9.18 (53.77%)	17.79M
SCNIScinai Immunotherapeutics Ltd	$ 5.80 (42.86%)	29.37M
ASLNASLAN Pharmaceuticals Ltd	$ 1.36 (-46.67%)	1.16M
KZIAKazia Therapeutics Ltd	$ 0.5593 (-37.56%)	15.34M
LCFYLocafy Ltd	$ 3.5597 (-36.32%)	584.38k
NAASNaaS Technology Inc	$ 2.82 (-33.02%)	1.94M
ZENVZenvia Inc	$ 1.67 (-26.75%)	658.26k
FFIEFaraday Future Intelligent Electric Inc	$ 0.5152 (22.09%)	217.92M
NVDANVIDIA Corporation	$ 128.44 (-0.62%)	208.32M
SQQQProShares UltraPro Short QQQ	$ 7.46 (-0.67%)	155.14M
AMIXAutonomix Medical Inc	$ 1.3701 (121.70%)	154.81M
TSLATesla Inc	$ 252.64 (1.78%)	147.31M